These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2303145)

  • 1. Inhibition of ovulation with oral progestins--effectiveness in premenstrual syndrome.
    West CP
    Eur J Obstet Gynecol Reprod Biol; 1990; 34(1-2):119-28. PubMed ID: 2303145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone.
    Watson NR; Studd JW; Savvas M; Garnett T; Baber RJ
    Lancet; 1989 Sep; 2(8665):730-2. PubMed ID: 2570971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.
    Magos AL; Brincat M; Studd JW
    Br Med J (Clin Res Ed); 1986 Jun; 292(6536):1629-33. PubMed ID: 3087550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin.
    Mortola JF; Girton L; Fischer U
    J Clin Endocrinol Metab; 1991 Feb; 72(2):252A-252F. PubMed ID: 1846868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes.
    Halbreich U; Rojansky N; Palter S
    Fertil Steril; 1991 Dec; 56(6):1066-9. PubMed ID: 1743323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
    Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
    Thys-Jacobs S; Starkey P; Bernstein D; Tian J
    Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo.
    Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 1988; 67(2):159-66. PubMed ID: 3140572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridoxine (vitamin B6) and the premenstrual syndrome: a randomized crossover trial.
    Doll H; Brown S; Thurston A; Vessey M
    J R Coll Gen Pract; 1989 Sep; 39(326):364-8. PubMed ID: 2558186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate.
    Hellberg D; Claesson B; Nilsson S
    Int J Gynaecol Obstet; 1991 Mar; 34(3):243-8. PubMed ID: 1673942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome.
    Magos AL; Brewster E; Singh R; O'Dowd T; Brincat M; Studd JW
    Br J Obstet Gynaecol; 1986 Dec; 93(12):1290-6. PubMed ID: 3801360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy.
    Kirkham C; Hahn PM; Van Vugt DA; Carmichael JA; Reid RL
    Obstet Gynecol; 1991 Jul; 78(1):93-7. PubMed ID: 1828550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome.
    West CP; Hillier H
    Hum Reprod; 1994 Jun; 9(6):1058-63. PubMed ID: 7962376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome.
    Smith RN; Studd JW; Zamblera D; Holland EF
    Br J Obstet Gynaecol; 1995 Jun; 102(6):475-84. PubMed ID: 7632640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative mood changes during hormone replacement therapy: a comparison between two progestogens.
    Björn I; Bixo M; Nöjd KS; Nyberg S; Bäckström T
    Am J Obstet Gynecol; 2000 Dec; 183(6):1419-26. PubMed ID: 11120505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study.
    Leather AT; Studd JW; Watson NR; Holland EF
    Gynecol Endocrinol; 1999 Feb; 13(1):48-55. PubMed ID: 10368798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study.
    Wang M; Hammarbäck S; Lindhe BA; Bäckström T
    Acta Obstet Gynecol Scand; 1995 Nov; 74(10):803-8. PubMed ID: 8533564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol.
    O'Brien PM; Abukhalil IE
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):18-23. PubMed ID: 9914571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
    Freeman E; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1990 Jul; 264(3):349-53. PubMed ID: 2194047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.